JP2013523635A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523635A5
JP2013523635A5 JP2013501273A JP2013501273A JP2013523635A5 JP 2013523635 A5 JP2013523635 A5 JP 2013523635A5 JP 2013501273 A JP2013501273 A JP 2013501273A JP 2013501273 A JP2013501273 A JP 2013501273A JP 2013523635 A5 JP2013523635 A5 JP 2013523635A5
Authority
JP
Japan
Prior art keywords
active ingredient
melt
layer
protective layers
extruded film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013501273A
Other languages
English (en)
Japanese (ja)
Other versions
JP5749790B2 (ja
JP2013523635A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/026230 external-priority patent/WO2011119288A2/en
Publication of JP2013523635A publication Critical patent/JP2013523635A/ja
Publication of JP2013523635A5 publication Critical patent/JP2013523635A5/ja
Application granted granted Critical
Publication of JP5749790B2 publication Critical patent/JP5749790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013501273A 2010-03-26 2011-02-25 多層溶融押出フィルム Expired - Fee Related JP5749790B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31789310P 2010-03-26 2010-03-26
US61/317,893 2010-03-26
PCT/US2011/026230 WO2011119288A2 (en) 2010-03-26 2011-02-25 Multilayer melt-extruded film

Publications (3)

Publication Number Publication Date
JP2013523635A JP2013523635A (ja) 2013-06-17
JP2013523635A5 true JP2013523635A5 (enExample) 2014-04-10
JP5749790B2 JP5749790B2 (ja) 2015-07-15

Family

ID=43901622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501273A Expired - Fee Related JP5749790B2 (ja) 2010-03-26 2011-02-25 多層溶融押出フィルム

Country Status (6)

Country Link
US (1) US20110236443A1 (enExample)
EP (1) EP2552402B1 (enExample)
JP (1) JP5749790B2 (enExample)
KR (1) KR20130010482A (enExample)
CN (1) CN102821754B (enExample)
WO (1) WO2011119288A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
KR101790666B1 (ko) * 2017-06-27 2017-10-26 (주)조안엠앤에스 애완동물용 구강용해필름
IL304085B2 (en) * 2018-04-27 2025-09-01 Fresh Inset S A Preparations and articles containing complexes of 1-methylcyclopropane and alpha-cyclodextrin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA849081A (en) * 1967-03-02 1970-08-11 Du Pont Of Canada Limited PRODUCTION OF ETHYLENE/.alpha.-OLEFIN COPOLYMERS OF IMPROVED PHYSICAL PROPERTIES
US4645812A (en) * 1983-02-28 1987-02-24 Henkel Corporation Method of suspension polymerization of vinyl chloride
US4729190A (en) * 1983-10-27 1988-03-08 Ciba-Geigy Corporation Membrane-forming polymeric systems
US5272236A (en) 1991-10-15 1993-12-21 The Dow Chemical Company Elastic substantially linear olefin polymers
TW207987B (enExample) 1991-03-20 1993-06-21 Hoechst Ag
DE69222847T3 (de) * 1991-04-16 2005-09-15 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer festen dispersion
US5278272A (en) * 1991-10-15 1994-01-11 The Dow Chemical Company Elastic substantialy linear olefin polymers
ID16442A (id) 1996-01-22 1997-10-02 Dow Chemical Co Polimer etilena berat molekul ultra rendah
DE19852826A1 (de) * 1998-11-17 2000-05-18 Aventis Res & Tech Gmbh & Co Poly(alpha-1,4-D-Glucan)
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20040180077A1 (en) 2003-03-05 2004-09-16 Riker Donald K. Rapidly dissolving edible strips for treating obesity
US20050186257A1 (en) * 2004-02-20 2005-08-25 Todd Manegold Dissolvable film and method of manufacture
JP5336351B2 (ja) * 2006-03-24 2013-11-06 オクシリウム インターナショナル ホールディングス，インコーポレイティド ホットメルト押出しラミネートの調製方法
EP2120895A2 (en) * 2007-01-12 2009-11-25 MonoSol Rx LLC High dose film compositions and methods of preparation
JP5165428B2 (ja) * 2008-03-18 2013-03-21 日生化学株式会社 積層体

Similar Documents

Publication Publication Date Title
JP2013523635A5 (enExample)
AR089670A1 (es) Forma de dosificacion que comprende nicotina solida con reduccion de los trastornos organolepticos
WO2014062879A3 (en) Strip for the delivery of an oral care active and methods for applying oral care actives
PH12012502463A1 (en) Multilayer films for delivery of flavor
JP2010525073A5 (enExample)
HK1219096A1 (zh) 抗篡改的药物制剂
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
WO2012131463A3 (en) Controlled release pharmaceutical dosage forms
MX2016004423A (es) Peliculas polimericas de capas multiples.
JP2010510260A5 (enExample)
WO2019101800A3 (de) Taschenförmige oral auflösende filme mit hoher wirkstoffbeladung
ATE486593T1 (de) Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
HK1208353A1 (en) Solid dosage form
CL2015000375A1 (es) Composicion farmaceutica en forma de microparticulas que comprende un nucleo inerte y al menos una primera capa de principio activo; proceso de formacion de microparticulas; combinacion farmaceutica; kit farmaceutico; uso para tratar y/o prevenir edemas, enfermedades cardiovasculares, diabetes, hipertension, entre otras.
CL2012002909A1 (es) Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
WO2012061753A3 (en) Nanoimprint lithography formation of functional nanoparticles using dual release layers
BR112015030324A2 (pt) filme, combinação e método
MX2016004424A (es) Peliculas polimericas de capas multiples que contienen capas disipadoras de energia.
WO2014042779A3 (en) Conformal porous thin layer coating and method of making
BR112017014953A2 (pt) microglóbulos de liberação controlada em camadas e métodos para produção dos mesmos
PH12016502537A1 (en) Composite preparation comprising active ingredient-containing film coating layer
JP2015508411A5 (enExample)
WO2011119288A3 (en) Multilayer melt-extruded film
AR089765A1 (es) Un sistema para el suministro de un farmaco